Article Text

Download PDFPDF

Protocol
Protocol for creating new warnings on cigarette packs and evaluating their efficacy in a randomised experimental setting
  1. Christian Ben Lakhdar1,
  2. Antoine Deplancke2,
  3. Fabrice Le Lec2,
  4. Sophie Massin3,
  5. Anthony Piermatteo2,
  6. Nicolas Vaillant1,2
  1. 1LEM UMR 9221 CNRS, University of Lille, Lille, Hauts-de-France, France
  2. 2ETHICS EA 7446, Lille Catholic University, Lille, Hauts-de-France, France
  3. 3LEM UMR 9221 CNRS, Artois University, Arras, Hauts-de-France, France
  1. Correspondence to Professor Christian Ben Lakhdar; christian.ben-lakhdar{at}univ-lille.fr

Abstract

Introduction Tobacco smoking is one of the leading causes of preventable death. This is not inevitable as tobacco control tools have become more powerful and more effective. Among these, warnings on cigarette packs have proven to be somewhat effective. Our objective is to increase the efficacy of antismoking warnings by using innovative psychological approaches and to create an experimental setting for the evaluation of these new warnings based on behavioural indicators.

Methods and analysis First, we created new warnings based on three categories of motivational leverage and on harm reduction. New warnings with innovative texts and pictures were designed for each category and inserted on plain packs. We will then use standard indicators to compare their effect to that of control packs: plain pack without warning, plain pack with conventional warning and branded pack with conventional warning. Second, the novelty of our approach will consist in designing an experimental protocol that uses monetary incentives to evaluate the effect of warnings. Subjects will be able to ‘sacrifice’ part of their participation defrayal to purchase a good whose subjective value is related to one’s attitude towards smoking. These monetarily incentivised measures are designed to assess smokers’ immediate/mid-term intention to quit and non-smokers’ aversion to smoking. In both cases, the monetary amounts individuals accept to sacrifice may be a more reliable measure than declarative responses, which may be distorted by several hypothetical biases. In the end, we should be able to robustly measure the impact of our new warnings between intervention and control groups by using both traditional indicators and our new monetarily incentivised measure.

Ethics and dissemination The ethics committee of the Groupement des Hôpitaux de l’Institut Catholique de Lille approved the research protocol on 5 July 2019 (CIER 2019-22). Results will be presented at scientific meetings and published.

  • health economics
  • public health
  • statistics & research methods
http://creativecommons.org/licenses/by-nc/4.0/

This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors All authors substantially contributed to the conception and the design of the research. The first version of the manuscript was drafted by FLL, AD and AP. CBL and AP conceived the warning based on psychological leverage and harm reduction. FLL and AD designed the experimental framework, which was discussed and approved by the other authors. CBL, SM, NV and FLL applied for funding and conceived and drafted the literature reviews. All authors drafted the data analysis section and revised the work critically for important intellectual content and gave final approval for the submitted version.

  • Funding This work was supported by INSERM and IReSP, grant numbers 19II029-00 and 19II030-00.

  • Competing interests None declared.

  • Patient and public involvement Patients and/or the public were not involved in the design, or conduct, or reporting, or dissemination plans of this research.

  • Patient consent for publication Not required.

  • Provenance and peer review Not commissioned; externally peer reviewed.